Free Trial
Thank you for registering! Take a moment to confirm your subscription to MarketBeat Daily Ratings so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.

Vivos Therapeutics (VVOS) Insider Trading & Ownership

$2.29
+0.03 (+1.33%)
(As of 05/17/2024 08:54 PM ET)

Vivos Therapeutics (NASDAQ:VVOS) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
9.60%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$20,420.00
Number Of
Insiders Selling
(Last 12 Months)
0

VVOS Insider Buying and Selling by Quarter

Vivos Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/20/2023Ronald Kirk HuntsmanCEOBuy560$13.25$7,420.00  
6/16/2023Ronald Kirk HuntsmanCEOBuy600$13.50$8,100.00  
6/14/2023Ronald Kirk HuntsmanCEOBuy400$12.25$4,900.00  
(Data available from 1/1/2013 forward)

VVOS Insider Trading Activity - Frequently Asked Questions

Who is on Vivos Therapeutics's Insider Roster?

The list of insiders at Vivos Therapeutics includes Bradford K Amman, and Ronald Kirk Huntsman. Learn more on insiders at VVOS.

What percentage of Vivos Therapeutics stock is owned by insiders?

9.60% of Vivos Therapeutics stock is owned by insiders. Learn more on VVOS's insider holdings.

Which Vivos Therapeutics insiders have been buying company stock?

The following insider purchased VVOS shares in the last 24 months: Ronald Kirk Huntsman ($46,660.00).

How much insider buying is happening at Vivos Therapeutics?

Insiders have purchased a total of 2,680 VVOS shares in the last 24 months for a total of $46,660.00 bought.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:VVOS) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners